LCM
NKTR icon

Landscape Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Landscape Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
41,902
+4,995
+14% +$365K 0.19% 152
2026
Q1 		$2.66M Sell
36,907
-23,524
-39% -$1.34M 0.17% 188
2025
Q4 		$2.56M Buy
+60,431
New +$3.38M 0.17% 183
2023
Q1 		– Sell
-1,628
Closed -$55.2K – 740
2022
Q4 		$55.2K Hold
1,628
– – 0.01% 782
2022
Q3 		$78K Sell
1,628
-199
-11% -$11.8K 0.01% 912
2022
Q2 		$104K Buy
1,827
+900
+97% +$56.8K 0.01% 876
2022
Q1 		$75K Buy
+927
New +$137K 0.01% 899
2019
Q4 		– Sell
-2,291
Closed -$626K – 770
2019
Q3 		$626K Buy
2,291
+969
+73% +$355K 0.05% 353
2019
Q2 		$706K Hold
1,322
– – 0.06% 342
2019
Q1 		$666K Sell
1,322
-70
-5% -$41.5K 0.06% 345
2018
Q4 		$686K Buy
+1,392
New +$840K 0.06% 364
2017
Q2 		– Sell
-1,039
Closed -$191K – 408
2017
Q1 		$191K Hold
1,039
– – 0.02% 450
2016
Q4 		$191K Buy
+1,039
New +$211K 0.03% 480

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Landscape Capital Management's NKTR Position: Q2 2026 in Review

Landscape Capital Management increased its Nektar Therapeutics (NKTR) stake by 14% in Q2 2026, buying an estimated $365K and bringing the position to 41,902 shares worth $2.93M. The position accounts for 0.19% of the portfolio, ranked #152.

Landscape Capital Management first reported a position in NKTR in Q4 2016 and has held it in 13 quarters since. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Landscape Capital Management held 41,902 shares of Nektar Therapeutics worth $2.93M as of Q2 2026.
  • Landscape Capital Management bought 4,995 Nektar Therapeutics shares in Q2 2026, an estimated $365K.
  • Nektar Therapeutics made up 0.19% of Landscape Capital Management's portfolio in Q2 2026, its #152 holding.
  • Landscape Capital Management first reported a position in Nektar Therapeutics in Q4 2016 and has held it in 13 quarters since.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.